CYSTIC FIBROSIS GASTROINTESTINAL DISEASE

CYSTIC FIBROSIS GASTROINTESTINAL DISEASE was reported 25 times

CYSTIC FIBROSIS GASTROINTESTINAL DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Serotonin-4 Receptor Agonist [EPC] 1 0.0015
1 Recombinant Human Deoxyribonuclease 1 [EPC] 10 0.0005
2 Pediculicide [EPC] 1 0.0002
3 Aminoglycoside Antibacterial [EPC] 8 0.0002
4 Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] 3 0.0002
5 Bile Acid [EPC] 3 0.0001
6 Vitamin K [EPC] 1 0.0001
7 Stimulant Laxative [EPC] 1 0.0001
8 Arteriolar Vasodilator [EPC] 2 0.0000
9 Osmotic Laxative [EPC] 7 0.0000
10 Protease Inhibitor [EPC] 1 0.0000
11 Muscle Relaxant [EPC] 1 0.0000
12 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
13 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
14 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
15 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
16 5-alpha Reductase Inhibitor [EPC] 1 0.0000
17 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
18 Fluoroquinolone Antibacterial [EPC] 1 0.0000
19 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
20 Azole Antifungal [EPC] 1 0.0000
21 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
22 Corticosteroid [EPC] 7 0.0000
23 Estrogen [EPC] 1 0.0000
24 Expectorant [EPC] 1 0.0000
25 Thiazide Diuretic [EPC] 1 0.0000
26 Vitamin C [EPC] 2 0.0000
27 Insulin Analog [EPC] 2 0.0000
28 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
29 Benzodiazepine [EPC] 2 0.0000
30 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
31 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
32 Platelet Aggregation Inhibitor [EPC] 1 0.0000
33 Proton Pump Inhibitor [EPC] 1 0.0000